Compare TBPH & UTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TBPH | UTZ |
|---|---|---|
| Founded | 2013 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 912.7M |
| IPO Year | N/A | N/A |
| Metric | TBPH | UTZ |
|---|---|---|
| Price | $19.87 | $10.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $27.80 | $15.13 |
| AVG Volume (30 Days) | 376.6K | ★ 1.5M |
| Earning Date | 02-25-2026 | 02-12-2026 |
| Dividend Yield | N/A | ★ 2.16% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.58 | 0.06 |
| Revenue | $80,327,000.00 | ★ $1,437,681,000.00 |
| Revenue This Year | $70.78 | $3.17 |
| Revenue Next Year | N/A | $2.96 |
| P/E Ratio | ★ $32.64 | $162.56 |
| Revenue Growth | ★ 27.12 | 1.22 |
| 52 Week Low | $7.90 | $9.15 |
| 52 Week High | $21.03 | $14.67 |
| Indicator | TBPH | UTZ |
|---|---|---|
| Relative Strength Index (RSI) | 54.78 | 60.97 |
| Support Level | $18.78 | $10.21 |
| Resistance Level | $21.03 | $10.62 |
| Average True Range (ATR) | 0.81 | 0.37 |
| MACD | -0.15 | 0.03 |
| Stochastic Oscillator | 45.60 | 94.57 |
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Utz Brands Inc is a manufacturer of branded salty snacks. It produces a broad offering of salty snacks, including potato chips, tortilla chips, pretzels, cheese snacks, pork skins, pub/party mixes, and other snacks. Its iconic portfolio of authentic, craft, and better-for-you (BFY) brands, which includes Utz, Zapp's, On The Border, Golden Flake, and Boulder Canyon, among others, enjoys household penetration in the United States, where its products can be found in approximately half of U.S. household. The company operates in eight manufacturing facilities with a broad range of capabilities, and its products are distributed nationally to grocery, mass, club, convenience, drug, e-commerce and other retailers through direct shipments, distributors, and approximately 2,500 DSD routes.